ICS Maugeri Pavia
Pavia, 27100, Italy
Location status: Recruiting
NCT Number: NCT04557293
Obstructive sleep apnoea is the most common sleep disorder in general population, and is often associated with cognitive deficit, mood disorders, hypertension, diabetes mellitus, excessive daytime somnolence, nicturia and an increased cardiovascular and metabolic risk. The gold standard of treatment is Continuous Positive Airway Pressure (CPAP), but the adherence is often poor. The aim of our study is to investigate the effort based-decision making in patients with OSA, pre and post CPAP treatment, as a possible cause of poor adherence.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Pavia, 27100, Italy
Location status: Recruiting
Obstructive sleep apnea is a very common disease in general population (24% males; 9% females), characterized by frequent partial or total upper-airway collapse, intermittent hypoxia, arousal from sleep, change in blood pressure, excessive daytime sleepiness, cardiovascular and metabolic diseases, psychological and cognitive consequences. The gold standard treatment is Continuous Positive Airway Pressure (CPAP), but the adherence is often poor. Poor therapy adherence might be partially explained by executive deficits, decreasing the ability to plan and pursue longsighted behaviors entailing immediate costs/efforts. We investigate the cognitive function, in particular effort based-decision making and the relationship with excessive daytime somnolence and other cognitive function in a group of OSA patients and in control group. We assess cognitive function in OSA patients at the diagnosis moment and after six months of CPAP use.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment of Obstructive sleep apnoea syndrome with CPAP
Time frame: Change will be assesd before starting CPAP and after six months of CPAP treatment
Short and Long-term memory will be assessed with Digit span and California verbal learning test
Time frame: Change will be assesd before starting CPAPT and after six months of CPAP treatment
attentional and executive functioning will be assessed with Test of Attentional Performance (TAP)
Time frame: Change will be assesd before starting CPAPT and after six months of CPAP treatment
Planning will be assessed with Tower of London
Time frame: Change will be assesd before starting CPAPT and after six months of CPAP treatment
Will be assessed with Test Go-nogo
Time frame: Change will be assesd before starting CPAPT and after six months of CPAP treatment
Will be assesses with Rapid Serial Visual Presentation (RSVP)
Time frame: After six month of CPAP use
Administration of Digit span and California verbal Learning test
Time frame: After six month of CPAP use
Administration of Test attentional Performance
Time frame: After six month of CPAP use
Adimnistration of Tower of London Test
Time frame: After six month of CPAP use
administration of go no go Test
Time frame: After six month of CPAP use
Administration of Rapid Serial Visual Presentation (RSVP) test
Contact information is provided by the study sponsor or research team.
Istituti Clinici Scientifici Maugeri SpA
Other
Effort-based Decision-making as a Possible Predictor of Poor Adherence to CPAP Treatment in Obstructive Sleep Apnea
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04179981
Apnea, COPD
Detroit, Michigan, United States
View Trial DetailsNCT05527652
Abnormalities, Multiple, Airway Obstruction
Ann Arbor, Michigan, United States
View Trial DetailsNCT02431507
Apnea, Dyssomnias
San Francisco, California, United States
View Trial DetailsNCT06332404
Apnea, Dyssomnias
Edegem, Antwerp, Belgium
View Trial Details